Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OPRD1 encodes a G protein-coupled receptor that binds endogenous enkephalins and other opioids. It plays a key role in pain modulation, potentially influencing insulin secretion, and is implicated in diseases such as pain syndromes, irritable bowel syndrome, and metabolic disorders like type 2 diabetes. Selective activation or inhibition holds therapeutic potential, with careful consideration required for safety concerns like respiratory depression and seizure risk.
Upon ligand binding, activates G proteins, leading to inhibition of adenylate cyclase activity, decreased calcium ion currents, and increased potassium ion conductance.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opioid Receptor Delta 1 (OPRD1).